购物车
- 全部删除
- 您的购物车当前为空
Meseclazone has anti-inflammatory, analgesic, and antipyretic activity. Meseclazone shows inhibitory potency of secondary phase ADP aggregation.
Meseclazone has anti-inflammatory, analgesic, and antipyretic activity. Meseclazone shows inhibitory potency of secondary phase ADP aggregation.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | 6-8周 | |
50 mg | ¥ 13,800 | 6-8周 | |
100 mg | ¥ 17,500 | 6-8周 |
产品描述 | Meseclazone has anti-inflammatory, analgesic, and antipyretic activity. Meseclazone shows inhibitory potency of secondary phase ADP aggregation. |
体内活性 | Intravenous administration of Meseclazone and other nonsteroidal anti-inflammatory drugs induced a dose-dependent inhibition of bronchoconstriction. This causing the following order of descending potency: isoproterenol congruent to indomethacin greater than fenoprofen greater than tolmetin greater than aspirin greater than naproxen congruent to ibuprofen greater than phenylbutazone greater than diflunisal greater than Meseclazone greater than 5-CSA. Meseclazone inhibits collagen-induced aggregation 1 and 4 hr after oral administration[1][2]. |
别名 | 美西拉宗, W2395, NSC297623 |
分子量 | 239.65 |
分子式 | C11H10ClNO3 |
CAS No. | 29053-27-8 |
密度 | 1.47g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容